Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children

Show simple item record

dc.contributor.author Feucht, Ute Dagmar
dc.contributor.author Kinzer, M.
dc.contributor.author Kruger, Mariana
dc.date.accessioned 2008-04-07T12:01:45Z
dc.date.available 2008-04-07T12:01:45Z
dc.date.issued 2007-12
dc.description.abstract The aim of this study was to determine the reasons for delay of antiretroviral therapy (ART) in eligible HIV-infected children after the implementation of the South African National ART programme in April 2004, and to describe implemented interventions to improve ART access. This descriptive, retrospective audit included all HIV-infected children attending an ART clinic from April to December 2004, summarizing the following: (i) demographic data; (ii) HIV disease stage; (iii) CD4+ counts/percentages; (iv) ART eligibility and (v) reasons for ART delay. There were 276 study participants with a mean age of 4 years 4 months (range: 1 month–13 years). According to the South African national guidelines, 243 children were eligible for ART, but only 96 children were initiated on treatment during the study period, which was 39.5% of the eligible group and 34.8% of the total group. Important reasons for treatment delay were: (i) co-infection with tuberculosis (26.4%); (ii) lack of human resources (20.3%); (iii) socio-economic obstacles (17.3%) and (iv) incorrect disease stage classification (13.7%). Paediatric ART clinics need to co-operate closely with existing tuberculosis clinics for the effective management of tuberculosis co-infection; address socio-economic factors of HIV-affected families, especially the legal guardianship in orphans and improve their own staff capacity and the education of medical staff in HIV/AIDS management. en
dc.format.extent 120852 bytes
dc.format.mimetype application/pdf
dc.identifier.citation Feucht, UD, Kinzer, M & Kruger, M 2007, 'Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children', Journal of Tropical Pediatrics, vol. 53, no. 6, pp. 398-402. [http://tropej.oxfordjournals.org/] en
dc.identifier.issn 1465-3664
dc.identifier.other 10.1093/tropej/fmm060
dc.identifier.uri http://hdl.handle.net/2263/4885
dc.language.iso en en
dc.publisher Oxford University Press en
dc.rights Oxford University Press. This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Journal of tropical Pediatrics following peer review. The definitive publisher-authenticated version is available online at: http://tropej.oxfordjournals.org/cgi/reprint/53/6/398. en
dc.subject Antiretroviral therapy (ART) en
dc.subject Children en
dc.subject South Africa (SA) en
dc.subject Human immunodeficiency virus (HIV) en
dc.subject.lcsh AIDS (Disease) in children
dc.subject.lcsh Antiretroviral agents
dc.subject.lcsh Tuberculosis -- Complications
dc.subject.lcsh Human capital
dc.subject.lcsh Socio-economics
dc.title Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children en
dc.type Postprint Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record